Evista and Swelling face - a phase IV clinical study of FDA data

Summary:

Swelling face is reported as a side effect among people who take Evista (raloxifene hydrochloride), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Forteo, and have Systemic lupus erythematosus.

The phase IV clinical study analyzes which people have Swelling face when taking Evista. It is created by eHealthMe based on reports of 25,442 people who have side effects when taking Evista from the FDA, and is updated regularly.

What is Evista?

Evista has active ingredients of raloxifene hydrochloride. It is often used in osteoporosis. eHealthMe is studying from 25,891 Evista users. Check the latest studies of Evista.

What is Swelling face?

Swelling face is found to be associated with 1,900 drugs and 2,206 conditions by eHealthMe. Check the latest studies of Swelling face.

On Jul, 05, 2026

25,442 people reported to have side effects when taking Evista.
Among them, 99 people (0.39%) have Swelling face.

Among these 99 people:

How long have people been on Evista when they have Swelling face? *

What is the gender of people who have Swelling face when taking Evista? *

female: 98.97 %
male: 1.03 %

What is the age of people who have Swelling face when taking Evista? *

What are other drugs people take besides Evista? *

What are other side effects people have besides Swelling face? *

Pain: 48 people, 48.48%
Sinusitis (inflammation of sinus): 45 people, 45.45%
Swelling: 41 people, 41.41%
Bone Pain: 41 people, 41.41%
Bone Disorder: 40 people, 40.40%
Oedema Peripheral (superficial swelling): 40 people, 40.40%
Asthma: 39 people, 39.39%
Fatigue (feeling of tiredness): 37 people, 37.37%
Stress And Anxiety: 36 people, 36.36%
Pneumonia: 34 people, 34.34%

What are the existing conditions these people have? *

Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 28 people, 28.28%
Hypothalamo-Pituitary Disorder (loss of function in an endocrine gland due to failure of the pituitary gland to secrete hormones which stimulate that gland's function): 11 people, 11.11%
Acromegaly (body produces too much growth hormone, leading to excess growth of body tissues): 11 people, 11.11%
Thrombocytopenia (decrease of platelets in blood): 11 people, 11.11%
Bone Atrophy (decrease in bone mass): 11 people, 11.11%
Sinusitis (inflammation of sinus): 7 people, 7.07%
Glaucoma (increased fluid pressure in the eye with vision loss): 6 people, 6.06%
Catarrh (inflammation of mucous membranes, especially of the nose and throat): 5 people, 5.05%
High Blood Pressure: 4 people, 4.04%
Diabetes: 3 people, 3.03%

* Approximation only. Some reports may have incomplete information.

Do you take Evista and have Swelling face?

- Check whether Swelling face is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Evista:

Evista (25,891 reports)

Swelling face treatments and more:

Swelling face (70,017 reports)

Browse all side effects of Evista:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Swelling face:

Swelling face (1,900 drugs)

Browse all the conditions that are associated with Swelling face:

Swelling face (2,206 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on raloxifene hydrochloride (the active ingredients of Evista) and Evista (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.